|
1
|
Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
|
J Biol Chem
|
1998
|
2.10
|
|
2
|
Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK.
|
J Biol Chem
|
2000
|
1.38
|
|
3
|
Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt.
|
J Biol Chem
|
1999
|
1.31
|
|
4
|
Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments.
|
Circ Res
|
1999
|
1.26
|
|
5
|
Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat vascular smooth muscle cells. Possible requirement of Gq-mediated p21ras activation coupled to a Ca2+/calmodulin-sensitive tyrosine kinase.
|
J Biol Chem
|
1996
|
1.18
|
|
6
|
Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells.
|
Hypertension
|
1999
|
1.17
|
|
7
|
Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells.
|
Hypertension
|
2000
|
1.07
|
|
8
|
Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
|
Endocrinology
|
1999
|
0.96
|
|
9
|
Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by angiotensin II.
|
Endocrinology
|
2000
|
0.96
|
|
10
|
Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases.
|
J Am Soc Nephrol
|
1999
|
0.94
|
|
11
|
Effect of pertussis toxin treatment on postjunctional alpha-1 and alpha-2 adrenoceptor function in the cardiovascular system of the pithed rat.
|
J Pharmacol Exp Ther
|
1989
|
0.92
|
|
12
|
Lysophosphatidylcholine stimulates MAP kinase activity in rat vascular smooth muscle cells.
|
Hypertension
|
1998
|
0.86
|
|
13
|
Epidermal growth factor receptor is indispensable for c-Fos expression and protein synthesis by angiotensin II.
|
Eur J Pharmacol
|
1999
|
0.84
|
|
14
|
5-hydroxytryptamine stimulates phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures.
|
J Cardiovasc Pharmacol
|
2000
|
0.83
|
|
15
|
PYK2/CAKbeta represents a redox-sensitive tyrosine kinase in vascular smooth muscle cells.
|
Biochem Biophys Res Commun
|
2000
|
0.83
|
|
16
|
N-acetylcysteine inhibits angiotensin ii-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor.
|
Biochem Biophys Res Commun
|
2001
|
0.83
|
|
17
|
Differential effect of pertussis toxin on pre- and postjunctional alpha 2-adrenoceptors in the cardiovascular system of the pithed rat.
|
Eur J Pharmacol
|
1988
|
0.80
|
|
18
|
Neurobiological actions of cocaine in the hippocampus.
|
Ann N Y Acad Sci
|
1996
|
0.79
|
|
19
|
3-Morpholinosyndnonimine inhibits 5-hydroxytryptamine-induced phosphorylation of nitric oxide synthase in endothelial cells.
|
Cell Mol Biol (Noisy-le-grand)
|
2003
|
0.76
|
|
20
|
Unique regulation of c-Jun N-terminal kinase by PYK2/CAK-beta in angiotensin II-stimulated vascular smooth muscle cells.
|
Biochem Biophys Res Commun
|
2001
|
0.76
|
|
21
|
The effect of pertussis toxin on alpha 1-adrenoceptor-mediated vasoconstriction by the full agonist, cirazoline, and the partial agonist, (-)-dobutamine, in pithed rats.
|
Fundam Clin Pharmacol
|
1991
|
0.75
|